
PDA Releases Report on Passive Thermal Protection Systems
The PDA report discusses qualification and operational handling of passive thermal protection systems.
The Parenteral Drug Association (PDA) has released
According to PDA, many factors play into the decision to use a passive system versus an active system. TR 72 assists “stakeholders in the supply chain to preserve the quality, safety, and efficacy of pharmaceutical and biological products during distribution,” said PDA in a press release.
Source:
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.